HSCI has signed a collaborative research and training agreement with Qatar Biomedical Research Institute (QBRI), a research institute under Hamad Bin Khalifa University (HBKU). The five-year initiative includes technical training and research in stem cell biology, with the goal of working toward viable treatments for diabetes.
The prevalence of type 1 and 2 diabetes is a rising global healthcare challenge. Recent advances in stem cell research, led by HSCI scientists, have the potential to help both type 1 and type 2 diabetes patients cope with their condition by...
Dana-Farber Cancer Institute Harvard Medical School Broad Institute of MIT and Harvard
Zuzana Totova's laboratory is group of physicians and scientists who are passionate about tackling important questions in cancer biology, and aim to...
Advances in engineering blood cells, treating diabetes, regenerating joints, and growing organs
On May 31, 2018, Harvard Stem Cell Institute (HSCI) faculty members shared their research updates at the Harvard Medical School (HMS) Alumni Reunion symposium. Their work showcased the breadth of research being conducted across the HSCI network, both at Harvard University and its...